252 related articles for article (PubMed ID: 20435480)
1. Synthesis, anticoagulant and PIVKA-II induced by new 4-hydroxycoumarin derivatives.
Abdelhafez OM; Amin KM; Batran RZ; Maher TJ; Nada SA; Sethumadhavan S
Bioorg Med Chem; 2010 May; 18(10):3371-8. PubMed ID: 20435480
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and pharmacological investigations of some 4-hydroxycoumarin derivatives.
Manolov I; Danchev ND
Arch Pharm (Weinheim); 2003 Apr; 336(2):83-94. PubMed ID: 12761761
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, structure, toxicological and pharmacological investigations of 4-hydroxycoumarin derivatives.
Manolov I; Maichle-Moessmer C; Danchev N
Eur J Med Chem; 2006 Jul; 41(7):882-90. PubMed ID: 16647160
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and anticoagulant activities of substituted 2,4-diketochromans, biscoumarins, and chromanocoumarins.
Manolov I; Maichle-Moessmer C; Nicolova I; Danchev N
Arch Pharm (Weinheim); 2006 Jun; 339(6):319-26. PubMed ID: 16649158
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of 3-amino-4-hydroxy coumarin and dihydroxy-phenyl coumarins as novel anticoagulants.
Danis O; Yuce-Dursun B; Gunduz C; Ogan A; Sener G; Bulut M; Yarat A
Arzneimittelforschung; 2010; 60(10):617-20. PubMed ID: 21125812
[TBL] [Abstract][Full Text] [Related]
6. PIVKA-II is a candidate marker for monitoring the effects of the oral anticoagulant warfarin.
Lee W; Chung HJ; Kim S; Jang S; Park CJ; Chi HS; Chun S; Min WK
Clin Biochem; 2010 Sep; 43(13-14):1177-9. PubMed ID: 20621074
[TBL] [Abstract][Full Text] [Related]
7. A study of the relationship between the pharmacokinetics and the pharmacodynamics of the 4-hydroxycoumarin anticoagulants warfarin, difenacoum and brodifacoum in the rabbit.
Breckenridge AM; Cholerton S; Hart JA; Park BK; Scott AK
Br J Pharmacol; 1985 Jan; 84(1):81-91. PubMed ID: 3978316
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of zeta-crystallin by Coumarins: a structure-activity study.
Duhaiman AS
J Protein Chem; 1996 Apr; 15(3):261-4. PubMed ID: 8804573
[TBL] [Abstract][Full Text] [Related]
9. New series of 6-substituted coumarin derivatives as effective factor Xa inhibitors: synthesis, in vivo antithrombotic evaluation and molecular docking.
Amin KM; Abdel Gawad NM; Abdel Rahman DE; El Ashry MK
Bioorg Chem; 2014 Feb; 52():31-43. PubMed ID: 24316885
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, toxicological, and pharmacological assessment of some oximes and aldehyde condensation products of 4-hydroxycoumarin.
Manolov I; Danchev ND
Arch Pharm (Weinheim); 1999 Jul; 332(7):243-8. PubMed ID: 10450169
[TBL] [Abstract][Full Text] [Related]
11. Development of a cell culture/ELISA assay to detect anticoagulant rodenticides and its application to analysis of rodenticide treated grain.
Lawley WJ; Charlton AJ; Hughson EJ; Grundy HH; Brown PM; Jones A
J Agric Food Chem; 2006 Mar; 54(5):1588-93. PubMed ID: 16506805
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of C-3 aliphatic coumarins as vitamin K antagonists.
Montagut-Romans A; Boulven M; Jacolot M; Moebs-Sanchez S; Hascoët C; Hammed A; Besse S; Lemaire M; Benoit E; Lattard V; Popowycz F
Bioorg Med Chem Lett; 2017 Apr; 27(7):1598-1601. PubMed ID: 28254487
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antitumor activity of 4-hydroxycoumarin derivatives.
Jung JC; Lee JH; Oh S; Lee JG; Park OS
Bioorg Med Chem Lett; 2004 Nov; 14(22):5527-31. PubMed ID: 15482917
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, in vivo Anticoagulant Evaluation and Molecular Docking Studies of Bicoumarins Obtained from Furocoumarin Peucedanin.
Lipeeva AV; Khvostov MV; Baev DS; Shakirov MM; Tolstikova TG; Shults EE
Med Chem; 2016; 12(7):674-683. PubMed ID: 26825067
[TBL] [Abstract][Full Text] [Related]
15. Levels of acarboxy prothrombin (PIVKA-II) and coagulation factors in warfarin-treated patients.
Umeki S; Umeki Y
Med Lab Sci; 1990 Apr; 47(2):103-7. PubMed ID: 2381266
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, computational study and cytotoxic activity of new 4-hydroxycoumarin derivatives.
Stanchev S; Momekov G; Jensen F; Manolov I
Eur J Med Chem; 2008 Apr; 43(4):694-706. PubMed ID: 17614164
[TBL] [Abstract][Full Text] [Related]
17. [Significance of combined use of anticoagulants and antiplatelet agents in the early stage after prosthetic valve replacement].
Toyohira H; Nakamura K; Kariyazono H; Yamada K; Moriyama Y; Shimokawa S; Saigenji H; Taira A
Kyobu Geka; 1995 Aug; 48(9):749-55. PubMed ID: 7564036
[TBL] [Abstract][Full Text] [Related]
18. One-step synthesis and pharmacological activity of new (N-substituted)amino-spiroalkan-dione derivatives.
Bonsignore L; Loy G; Cottiglia F; Calignano A
Farmaco; 1997 Nov; 52(11):663-6. PubMed ID: 9550091
[TBL] [Abstract][Full Text] [Related]
19. [Anticoagulant action of a new synthetic derivative of 4-hydroxycoumarin and antagonism by synthetic vitamin K1 in the rat].
Thonnart N; Letist D; Reuse JJ
C R Seances Soc Biol Fil; 1973; 167(6):1081-5. PubMed ID: 4803162
[No Abstract] [Full Text] [Related]
20. Synthesis and structure-activity relationships of novel warfarin derivatives.
Gebauer M
Bioorg Med Chem; 2007 Mar; 15(6):2414-20. PubMed ID: 17275317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
